The oxylipin analog CS585 prevents platelet activation and thrombosis through activation of the prostacyclin receptorLivia Stanger, Michael Holinstat, Adriana Yamaguchi et al.|Blood|2023Cited by 18
The EPA oxylipin, 12-HEPE, directly regulates human platelet activityKrista Goerger, Michael Holinstat, Livia Stanger et al.|Journal of Lipid Research|2025Cited by 7
12-Hepe Regulates the Antiplatelet Effects of Epa, the ω-3 Fatty AcidKrista Goerger, Michael Holinstat, Theodore R. Holman et al.|Blood|2024Cited by 2
Abstract 4134384: Sotagliflozin, a Dual Inhibitor of Sodium-Glucose Transporters 1 and 2, Elicits Cardioprotective Effects Through Attenuation of Platelet Activation and ThrombosisLivia Stanger, Michael Holinstat, Andrew Rickenberg et al.|Circulation|2024Cited by 1
SOTAGLIFLOZIN, A FIRST-IN-CLASS SGLT1/2 INHIBITOR, INHIBITS CLOTTING POTENTIAL IN THE VESSEL VIA INHIBITION OF PLATELET ACTIVATION, INTEGRIN ACTIVATION, AND AGGREGATION IN HUMAN PLATELETSMichael Holinstat, Bertram Pitt, Livia Stanger et al.|Journal of the American College of Cardiology|2024Cited by 0